Caffeine for Prevention of Alzheimer’s Disease: Is the A_2A Adenosine Receptor Its Target?

Alzheimer’s disease (AD) is the most prevalent kind of dementia with roughly 135 million cases expected in the world by 2050. Unfortunately, current medications for the treatment of AD can only relieve symptoms but they do not act as disease-modifying agents that can stop the course of AD. Caffeine...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Stefania Merighi, Alessia Travagli, Manuela Nigro, Silvia Pasquini, Martina Cappello, Chiara Contri, Katia Varani, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Gessi
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2023-06-01
Цуврал:	Biomolecules
Нөхцлүүд:	A<sub>2A</sub> adenosine receptor Alzheimer’s disease amyloid beta caffeine neuroinflammation therapeutic target
Онлайн хандалт:	https://www.mdpi.com/2218-273X/13/6/967
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!